SCHEMBL10089991

SCHEMBL10089991

Cc1cc(C#N)cc(C(=O)NCc2ccc(OC(F)(F)F)cc2)c1NC(=O)c1cc(Cn2nnc(C(F)F)n2)nn1-c1ncccc1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR6 P46095 2/20 0.36
SLC2A1 P11166 3/20 0.34
SLC2A3 P11169 3/20 0.34
SLC2A4 P14672 3/20 0.34
SLC2A2 P11168 1/20 0.34
PDE2A O00408 1/20 0.33
ALDH1A1 P00352 3/20 0.32
HPGD P15428 3/20 0.32
CYP1A2 P05177 2/20 0.32
CYP2D6 P10635 2/20 0.32
CYP2C9 P11712 2/20 0.32
CYP2C19 P33261 2/20 0.32
PTGER4 P35408 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
KDM4E B2RXH2 2/20 0.32
KLKB1 P03952 1/20 0.32
CACNA1G O43497 1/20 0.32
CACNA1H O95180 1/20 0.32
CYP3A4 P08684 1/20 0.32
CACNA1C Q13936 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10090032 0.94 GPR6 (0.36) GPR6
SCHEMBL10089932 0.93 GPR6 (0.36) GPR6SLC2A1SLC2A3SLC2A4SLC2A2
SCHEMBL10090044 0.93 PDE2A (0.35) PDE2AALDH1A1HPGDCYP1A2CYP2D6
SCHEMBL10090035 0.92 SLC2A1 (0.36) GPR6SLC2A1SLC2A3SLC2A4SLC2A2
SCHEMBL10090008 0.90 HSD17B13 (0.38) GPR6MAPK1
SCHEMBL10089881 0.89 GPR6 (0.36) GPR6HPGDKLKB1ELANE
SCHEMBL13085263 0.88 ALDH1A1 (0.32) SLC2A1SLC2A3SLC2A4SLC2A2ALDH1A1
SCHEMBL13085295 0.88 SLC2A1 (0.32) SLC2A1SLC2A3SLC2A4SLC2A2ALDH1A1
SCHEMBL13085290 0.88 PIN1 (0.33) SLC2A1SLC2A3SLC2A4SLC2A2ALDH1A1
SCHEMBL10089975 0.87 SLC2A1 (0.35) GPR6SLC2A1SLC2A3SLC2A4SLC2A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2582695-B1 ANTHRANILIC ACID DIAMIDE DERIVATIVES WITH CYCLICAL SIDE CHAINS BAYER IP GMBH (DE) 2015-09-30 EP disclosed
US-8791143-B2 Anthranilic diamide derivatives having cyclic side-chains BAYER CROPSCIENCE AG (DE) 2014-07-29 US disclosed
US-20120010249-A1 Anthranilic diamide derivatives having cyclic side-chains BAYER CROPSCIENCE AG (DE) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010249-A1 Anthranilic diamide derivatives having cyclic side-chains DDT, ADCY1, ANTXR2 GPR6 2424/4885SLC2A1 3782/4885SLC2A3 3762/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.